Wyeth Investors Likely To Win Class Cert. In Pristiq Case
A New York federal judge on Thursday said he will likely grant class certification to a group of investors who claim Pfizer Inc. unit Wyeth Pharmaceuticals Inc. did not disclose serious...To view the full article, register now.
Already a subscriber? Click here to view full article